Method for preparing enzyme of dissolving staphylococcal bacteria, its derivative, and method for preparing the derivative
A technology for lysostaphinase and bacteria breaking, applied in the biological field, can solve the problems of high cost, the yield of lysostaphinase cannot meet large-scale preparation and the like, and achieves the effects of low cost, simple expression scheme and improved purification yield
Active Publication Date: 2010-08-18
HANGZHOU LION BIOTECH
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
The yield of expressing lysostaphin in the prior art cannot meet the requirements of large-scale preparation, and the cost of PEG modification is very high, so it is necessary to develop a method suitable for large-scale preparation of lysostaphin and a low-cost modification technology
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
ionic strength | aaaaa | aaaaa |
purity | aaaaa | aaaaa |
Login to View More
Abstract
This invention relates to a method for preparing lysostaphin and its derivatives. The method comprises: designing and synthesizing lysostaphin gene, inserting lysostaphin gene into the digestion site of expression vector (plasmid pET), transforming E. coli, screening positive clones, culturing, inducing the expression of target protein, collecting E. coli, lysing, centrifuging, collecting the supernatant, and purifying the supernatant through chromatography. The method has such advantages as simple process, high expression level, simple purification, high yield, soluble product, and no requirement for renaturation, and is suitable for mass production. The lysostaphin derivatives are obtained by modifying lysostaphin with polyethylene glycol, and have such advantages as low immunogenicity and long half value period. The lysostaphin and its derivatives are suitable for treating Staphylococcus infection in clinic.
Description
technical field The invention relates to the field of biotechnology, in particular to a preparation method of lysostaphin and its derivative and the preparation method of the derivative. Background technique Staphylococcus (Staphylococcus) is a kind of Gram-positive coccus, which is widely distributed in nature, such as air, water, soil, feed and some articles, and also exists on the body surface, nasopharynx and intestinal tract of humans and animals. Most of them are not pathogenic, and a few can cause human and animal pathogenicity. Among them, Staphylococcus aureus is the most pathogenic, often causing purulent inflammation of the skin, tissues and organs, and is the cause of burn wound infection, acute liver failure and blood infection. The main pathogenic bacteria of diseases such as primary nephritis. Staphylococcus aureus also occurs simultaneously with G-sepsis bacteria, acting synergistically, seriously threatening the lives of patients. Enterotoxin produced by S...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/09C12N9/36C12N15/56C12N1/21
Inventor 刘国安刘沐荣康经武
Owner HANGZHOU LION BIOTECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com